European
Compliance Platform
If you manufacture medical devices outside the EU and want to sell in the EU market, appointing an EU Authorised Representative is a legal requirement — not an option. This guide explains exactly what you need, why it matters, and what to look for when choosing your AR.
An EU Authorised Representative (AR) is a natural or legal person established in the European Union who is explicitly designated by a non-EU manufacturer to act on their behalf in relation to specified tasks under the EU Medical Device Regulation (MDR 2017/745).
The legal basis is MDR Article 11. Any manufacturer without a registered place of business in the EU must, before placing a device on the EU market, designate an authorised representative. This representative becomes your legal point of contact for EU regulatory authorities, Notified Bodies, and market surveillance.
You must appoint an EU AR if your company is a medical device manufacturer established outside the EU or EEA, and you want to place CE-marked devices on the EU market. This applies to manufacturers in:
Registers in EUDAMED and is linked to each device they represent. Checked during market surveillance.
Named in the DoC alongside the manufacturer. Details must appear on the device label or packaging.
Primary EU legal contact for national competent authorities (BfArM, ANSM, SÚKL, etc.) for questions, investigations, and inspections.
Cooperates on vigilance — serious incidents, field safety corrective actions (FSCAs), and periodic safety update reports (PSURs).
Must have access to technical documentation and DoC, and provide them to authorities within legally required timeframes.
Cooperates on recalls, safety alerts, and market withdrawals. Ensures the manufacturer acts in accordance with EU requirements.
Under MDR Annex I, the label or accompanying documentation must include the name and address of the EU Authorised Representative with the prescribed AR symbol. Failing to include correct AR information is a frequent market surveillance finding.
An AR for Class I general medical devices is very different from one representing Class III implantables. Your AR should understand the regulatory pathway for your specific product type and risk class.
As EUDAMED becomes fully mandatory, your AR must be actively registered and capable of submitting and maintaining your device registrations. Ask about their EUDAMED infrastructure.
During a serious incident or market surveillance inspection, your AR must be reachable and able to act quickly. Ask about their incident response process and average response times.
Review the mandate agreement carefully — notice period for termination, liability caps, data access commitments, and what happens if the AR ceases operations.
Required under MDR for all 27 EU member states + EEA (Norway, Iceland, Liechtenstein).
Swiss Authorised Representative, required under MedDO for the Swiss market. Separate from EU AR.
UK Responsible Person, required under UK MDR 2002 for Great Britain market. Separate from EU AR.
Submit a request on ECP and receive responses from EU AR providers. Describe your device, target market, and timeline — we route your request to the right partners.
Submit a Request — Free